Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,027,670
  • Shares Outstanding, K 384,818
  • Annual Sales, $ 6,848 M
  • Annual Income, $ -4,714 M
  • EBIT $ -2,693 M
  • EBITDA $ -2,133 M
  • 60-Month Beta 1.60
  • Price/Sales 3.15
  • Price/Cash Flow N/A
  • Price/Book 1.33

Options Overview Details

View History
  • Implied Volatility 79.83% ( +3.34%)
  • Historical Volatility 87.01%
  • IV Percentile 88%
  • IV Rank 74.73%
  • IV High 92.67% on 12/18/24
  • IV Low 41.88% on 05/17/24
  • Put/Call Vol Ratio 0.31
  • Today's Volume 99,309
  • Volume Avg (30-Day) 138,994
  • Put/Call OI Ratio 0.77
  • Today's Open Interest 735,523
  • Open Int (30-Day) 699,733

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -2.93
  • Number of Estimates 12
  • High Estimate -1.90
  • Low Estimate -4.05
  • Prior Year 0.55
  • Growth Rate Est. (year over year) -632.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.94 +40.70%
on 01/13/25
48.92 -8.14%
on 01/07/25
+4.81 (+11.99%)
since 12/27/24
3-Month
31.94 +40.70%
on 01/13/25
57.69 -22.10%
on 10/29/24
-9.86 (-17.99%)
since 10/28/24
52-Week
31.94 +40.70%
on 01/13/25
170.47 -73.64%
on 05/24/24
-56.87 (-55.86%)
since 01/26/24

Most Recent Stories

More News
5 Stocks That Powered S&P 500 ETF in Trump's First Week

The S&P 500 had the best first week of a presidency since Ronald Reagan assumed power in 1985. The index gained about 2% last week on President Donald Trump’s economic growth policies, advancements in...

NFLX : 971.83 (-0.01%)
VST : 149.64 (+9.16%)
APH : 68.58 (+1.62%)
ORCL : 164.00 (+3.61%)
MRNA : 44.94 (+7.90%)
SPY : 604.52 (+0.86%)
Here's What to Expect From Moderna's Next Earnings Report

Moderna is scheduled to release its fourth-quarter earnings next month, and analysts anticipate a significant triple-digit profit dip.

XLV : 146.52 (-0.70%)
$SPX : 6,067.70 (+0.92%)
MRNA : 44.94 (+7.90%)
Why Moderna Stock Jumped Over 20% This Week

Are you ready for artificial intelligence (AI)-driven mRNA vaccines?

MRNA : 44.94 (+7.90%)
3 Things You Need to Know if You Buy Moderna Today

Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech that'll never recover its former glory -- which it built on the success of its coronavirus...

MRNA : 44.94 (+7.90%)
3 Beaten-Down Stocks That Haven't Been This Cheap in More Than 3 Years: Are They Bargain Buys?

If a stock is near its 52-week low, it may be a great time to buy it on the dip, particularly if you're bullish on its long-term prospects. But what about when it's trading at more of a discount, and is...

PEP : 150.25 (-2.82%)
MRNA : 44.94 (+7.90%)
HSY : 149.73 (-2.60%)
Analysts Predict 1,250% Upside for This ‘Strong Buy’ Quantum Computing Stock in 2025... But Investors Should Stay Away

Zapata Computing has ties to the red-hot quantum computing market but don't be fooled. Its business ceased operations last year.

IBM : 225.66 (+0.68%)
ZPTA : 0.0026 (-35.00%)
MRNA : 44.94 (+7.90%)
Moderna Retains Retail Support With European COVID-19 Vaccine Tender Win, Stock Hits 2-Week High

The agreement, which spans up to four years, allows 17 participating countries access to Moderna’s vaccine in various formats.

XLV : 146.52 (-0.70%)
IVV : 607.49 (+0.85%)
MRNA : 44.94 (+7.90%)
SPY : 604.52 (+0.86%)
XBI : 93.18 (+0.62%)
Stocks See Support as Trump Softens Tariff Rhetoric

The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.06%. March E-mini S&P futures (ESH25...

AMAT : 172.85 (-0.99%)
VZ : 40.40 (-0.59%)
ADI : 209.52 (-2.74%)
TXN : 180.57 (-3.45%)
ABNB : 131.05 (+1.62%)
$IUXX : 21,463.04 (+1.59%)
ZNH25 : 109-055 (+0.13%)
ESH25 : 6,090.25 (-0.11%)
QCOM : 171.55 (+0.22%)
GFS : 41.20 (+0.05%)
$DOWI : 44,850.35 (+0.31%)
SPY : 604.52 (+0.86%)
Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats

MRNA : 44.94 (+7.90%)
Stocks Finish Higher on Strong Corporate Earnings

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.92%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.22%. March E-mini S&P...

AMAT : 172.85 (-0.99%)
GOLF : 67.34 (-1.58%)
VEEV : 232.24 (+2.87%)
$IUXX : 21,463.04 (+1.59%)
ELV : 405.40 (-1.42%)
ASML : 683.35 (-0.99%)
ZNH25 : 109-055 (+0.13%)
PLXS : 144.53 (+0.68%)
ESH25 : 6,090.25 (-0.11%)
GFS : 41.20 (+0.05%)
UNP : 249.16 (-2.07%)
LRCX : 74.51 (-1.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 50.88
2nd Resistance Point 48.01
1st Resistance Point 46.48
Last Price 44.94
1st Support Level 42.08
2nd Support Level 39.21
3rd Support Level 37.68

See More

52-Week High 170.47
Fibonacci 61.8% 117.55
Fibonacci 50% 101.21
Fibonacci 38.2% 84.86
Last Price 44.94
52-Week Low 31.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar